EcoDrugPlus

Tubulin Beta 4a Class Iva

Ensembl ID : ENSDORG00000030020
Gene Symbol: TUBB4A
3 Cross references
89 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSDORG00000028433
Gene Symbol: TUBB6
3 Cross references
141 Possible Orthologues:

Tubulin Beta Chain-Like

Ensembl ID : ENSDORG00000029897
Gene Symbol: LOC105995646
4 Cross references
179 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSDORG00000029828
Gene Symbol: TUBB
4 Cross references
255 Possible Orthologues:

Tubulin Beta-2b Chain

Ensembl ID : ENSDORG00000029767
Gene Symbol: LOC105985961
4 Cross references
187 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSDORG00000026783
Gene Symbol: TP53
3 Cross references
251 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSDORG00000002350
Gene Symbol: TYR
1 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSDORG00000010289
Gene Symbol: TH
3 Cross references
188 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSDORG00000010102
Gene Symbol: TYK2
3 Cross references
197 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin Like And Egf Like Domains 1

Ensembl ID : ENSDORG00000007010
Gene Symbol: TIE1
2 Cross references
192 Possible Orthologues:

Tyrosine Kinase With Immunoglobulin-Like And Egf-Like Domains 1

Ensembl ID : ENSDORG00000024284
Gene Symbol: TIE1
1 Cross references
204 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSDORG00000023174
Gene Symbol: LOC105987800
2 Cross references
254 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).